Greenwood Gearhart Inc. Acquires 846 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Greenwood Gearhart Inc. raised its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 89.9% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,787 shares of the healthcare conglomerate's stock after buying an additional 846 shares during the quarter. Greenwood Gearhart Inc.'s holdings in UnitedHealth Group were worth $904,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently modified their holdings of the company. Norges Bank acquired a new stake in UnitedHealth Group in the 4th quarter worth about $6,375,744,000. Raymond James Financial Inc. acquired a new stake in UnitedHealth Group during the fourth quarter worth approximately $1,914,740,000. Amundi raised its holdings in UnitedHealth Group by 97.2% in the 4th quarter. Amundi now owns 6,069,100 shares of the healthcare conglomerate's stock valued at $3,183,132,000 after acquiring an additional 2,991,470 shares in the last quarter. Proficio Capital Partners LLC grew its holdings in shares of UnitedHealth Group by 76,830.4% during the 4th quarter. Proficio Capital Partners LLC now owns 1,888,641 shares of the healthcare conglomerate's stock worth $955,388,000 after purchasing an additional 1,886,186 shares in the last quarter. Finally, Franklin Resources Inc. raised its stake in UnitedHealth Group by 10.7% in the fourth quarter. Franklin Resources Inc. now owns 8,923,770 shares of the healthcare conglomerate's stock valued at $4,514,178,000 after purchasing an additional 861,854 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company's stock.

UnitedHealth Group Trading Down 22.0 %

Shares of NYSE UNH traded down $128.94 during midday trading on Friday, reaching $456.10. The stock had a trading volume of 29,048,929 shares, compared to its average volume of 4,364,426. UnitedHealth Group Incorporated has a twelve month low of $438.50 and a twelve month high of $630.73. The company's 50 day moving average price is $512.95 and its 200 day moving average price is $540.29. The firm has a market cap of $417.20 billion, a price-to-earnings ratio of 29.43, a price-to-earnings-growth ratio of 1.37 and a beta of 0.61. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. During the same period in the prior year, the firm earned $6.91 earnings per share. As a group, sell-side analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were paid a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a yield of 1.84%. The ex-dividend date was Monday, March 10th. UnitedHealth Group's dividend payout ratio (DPR) is currently 54.19%.

Wall Street Analyst Weigh In

UNH has been the subject of several analyst reports. Mizuho boosted their target price on shares of UnitedHealth Group from $600.00 to $650.00 and gave the company an "outperform" rating in a research report on Wednesday, April 9th. Piper Sandler reduced their target price on UnitedHealth Group from $605.00 to $600.00 and set an "overweight" rating on the stock in a report on Thursday, January 2nd. HSBC upgraded UnitedHealth Group from a "hold" rating to a "buy" rating and set a $595.00 price objective for the company in a research report on Friday, January 10th. Truist Financial boosted their target price on UnitedHealth Group from $610.00 to $660.00 and gave the stock a "buy" rating in a research note on Friday, April 11th. Finally, Hsbc Global Res upgraded shares of UnitedHealth Group from a "hold" rating to a "strong-buy" rating in a research report on Friday, January 10th. Twenty-one equities research analysts have rated the stock with a buy rating and three have assigned a strong buy rating to the company's stock. According to data from MarketBeat, the company currently has an average rating of "Buy" and an average target price of $632.85.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.